Multimodal Ocular Diagnosis-Guided Precision Acupuncture and Lifestyle Intervention for PCOS
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is designed as a prospective, multicenter, parallel-group randomized controlled trial to evaluate the effectiveness of a "precision acupuncture + personalized lifestyle" intervention, guided by dynamic multimodal risk monitoring based on the four diagnostic methods of Traditional Chinese Medicine (TCM), in improving insulin resistance in patients with polycystic ovary syndrome (PCOS). Compared with "conventional acupuncture + standard lifestyle intervention," the study will primarily assess changes in the homeostatic model assessment of insulin resistance (HOMA-IR) after 12 weeks of treatment. The safety of the intervention, improvements in endocrine and metabolic profiles, menstrual and ovulatory outcomes, psychological status, quality of life, and health-economic outcomes will also be evaluated. The study aims to provide evidence for establishing an intelligent and individualized clinical management model for PCOS.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18-40 lat
- •Wskaźnik masy ciała 25-40 kg/m²
- •Rozpoznanie zespołu policystycznych jajników selon kryteria Rotterdamskie z 2003 roku
- •Chęć dobrowolnego udziału w badaniu i możliwość wyrażenia świadomej zgody
✗ Disqualifies
- •Podwyższony poziom androgenów spowodowany innymi przyczynami (zaburzenia tarczycy, inne choroby)
- •Choroby nerek, wątroby, choroby autoimmunologiczne lub nowotwory
- •Cukrzyca typu 1 lub zbyt wysoki poziom glukozy we krwi
- •Używanie leków wpływających na wyniki badań w ostatnich 3 miesiącach
- •Ciśnienie krwi powyżej 160/100 mmHg
- •Ciąża, karmienie piersią lub planowanie ciąży podczas badania
- •Akupunktura przez co najmniej 2 miesiące przed badaniem
- •Codzienne palenie lub picie alkoholu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 40 Years
- Last updated (source)
- September 9, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (2)
Beijing Haidian Hospital
Beijing, China
Peking University Third Hospital
Beijing, China
Trial contact
Haolin Zhang, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/10/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.